Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|August 10, 2021
Cancer and immunotherapy: a role for microbiota compositionFiona Pham, Fabien Moinard-Butot, Clélia Coutzac, et al.
Bulletin Du Cancer|April 10, 2026
[Cardiovascular toxicities of major oral targeted therapies used in solid tumor]Simon Nannini, Clément Droesch, Emilie Schultz, et al.
Clinical Genitourinary Cancer|July 29, 2025
Impact of gastrectomy on cabozantinib exposure: Clinical case of a patient with clear renal cell carcinomaSanae Kdadri, Fabien Moinard-Butot, Antonin Schmitt, et al.
Frontiers in Immunology|December 31, 2024
Case report: Long-term response to a combination of immune checkpoint inhibitors as a single treatment for multiple synchronous cancers: a case studyNour Ghammem, Herve Bischoff, Pascale Chiappa, et al.
Pharmaceutics|November 27, 2021
Antitumor Immune Response Triggered by Metal-Based Photosensitizers for Photodynamic Therapy: Where Are We?Alain C Jung, Fabien Moinard-Butot, Chloé Thibaudeau, et al.
Journal of Medical Case Reports|September 17, 2023
Solitary acrometastasis of the phalanx as initial presentation of an oligometastatic Kirsten rat sarcoma viral oncogene homolog-mutated lung adenocarcinoma: a case reportAlexandra-Ioana Pușcașu, Fabien Moinard-Butot, Delphine Antoni, et al.
Cancers|September 14, 2024
Brain Metastases as Inaugural Sign of Non-Small Cell Lung Carcinoma: Case Series and Review of LiteratureAlexandra Pușcașu, Fabien Moinard-Butot, Simon Nannini, et al.
Clinical Genitourinary Cancer|July 11, 2026
De-escalation of Treatment in Metastatic Renal Cell Carcinoma: Why? How? Who? When?Fabien Moinard-Butot, Simon Nannini, Gwenaëlle Gravis, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Spontaneous Regression of Clear Cell Renal Cell Carcinoma Metastases or Immune Restoration?Clara Vacheret, Fabien Moinard-Butot, Lucile Reberol, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 20, 2024
Antibody-Drug Conjugates as Novel Therapeutic Agents for Non-Small Cell Lung Carcinoma with or without Alterations in Oncogenic DriversLaura Bender Somme, Christos Chouaid, Fabien Moinard-Butot, et al.
Pageof 3